PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274 | +18.1% | 8,940 | +46.3% | 0.02% | +10.5% |
| Q2 2023 | $232 | -6.8% | 6,110 | 0.0% | 0.02% | -5.0% |
| Q1 2023 | $249 | +5.5% | 6,110 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $236 | -99.9% | 6,110 | 0.0% | 0.02% | -33.3% |
| Q3 2022 | $325,000 | +38.3% | 6,110 | +51.6% | 0.03% | +42.9% |
| Q2 2022 | $235,000 | -23.7% | 4,030 | 0.0% | 0.02% | -12.5% |
| Q1 2022 | $308,000 | +8.1% | 4,030 | -14.3% | 0.02% | +4.3% |
| Q2 2021 | $285,000 | -13.4% | 4,700 | 0.0% | 0.02% | -23.3% |
| Q1 2021 | $329,000 | +8.6% | 4,700 | -31.9% | 0.03% | -16.7% |
| Q2 2020 | $303,000 | +31.2% | 6,900 | 0.0% | 0.04% | +9.1% |
| Q1 2020 | $231,000 | -26.2% | 6,900 | 0.0% | 0.03% | -29.8% |
| Q4 2019 | $313,000 | – | 6,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |